PNC Financial Services Group’s Nektar Therapeutics NKTR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
|
|||||
|
2025
Q1 | $273 | Buy |
|
|||||
|
2024
Q1 | – | Sell |
|
|||||
|
2023
Q4 | $57 | Buy |
|
|||||
|
2023
Q3 | – | Sell |
|
|||||
|
2023
Q2 | $222 | Buy |
|
|||||
|
2023
Q1 | $246 | Sell |
|
|||||
|
2022
Q4 | $5.04K | Sell |
|
|||||
|
2022
Q3 | $63K | Buy |
|
|||||
|
2022
Q2 | $29K | Buy |
|
|||||
|
2022
Q1 | $38K | Sell |
|
|||||
|
2021
Q4 | $134K | Buy |
|
|||||
|
2021
Q3 | $112K | Buy |
|
|||||
|
2021
Q2 | $102K | Sell |
|
|||||
|
2021
Q1 | $122K | Buy |
|
|||||
|
2020
Q4 | $88K | Buy |
|
|||||
|
2020
Q3 | $83K | Sell |
|
|||||
|
2020
Q2 | $195K | Sell |
|
|||||
|
2020
Q1 | $151K | Sell |
|
|||||
|
2019
Q4 | $327K | Buy |
|
|||||
|
2019
Q3 | $200K | Sell |
|
|||||
|
2019
Q2 | $887K | Buy |
|
|||||
|
2019
Q1 | $371K | Sell |
|
|||||
|
2018
Q4 | $371K | Buy |
|
|||||
|
2018
Q3 | $660K | Sell |
|
|||||
|
2018
Q2 | $671K | Sell |
|
|||||
|
2018
Q1 | $4.36M | Sell |
|
|||||
|
2017
Q4 | $2.95M | Buy |
|
|||||
|
2017
Q3 | $733K | Buy |
|
|||||
|
2017
Q2 | $534K | Sell |
|
|||||
|
2017
Q1 | $688K | Sell |
|
|||||
|
2016
Q4 | $377K | Buy |
|
|||||
|
2016
Q3 | $414K | Buy |
|
|||||
|
2016
Q2 | $306K | Sell |
|
|||||
|
2016
Q1 | $401K | Sell |
|
|||||
|
2015
Q4 | $957K | Buy |
|
|||||
|
2015
Q3 | $584K | Sell |
|
|||||
|
2015
Q2 | $683K | Buy |
|
|||||
|
2015
Q1 | $587K | Sell |
|
|||||
|
2014
Q4 | $1.01M | Buy |
|
|||||
|
2014
Q3 | $786K | Sell |
|
|||||
|
2014
Q2 | $846K | Sell |
|
|||||
|
2014
Q1 | $899K | Buy |
|
|||||
|
2013
Q4 | $468K | Buy |
|
|||||
|
2013
Q3 | $279K | Buy |
|
|||||
|
2013
Q2 | $140K | Buy |
|